Immix Biopharma Stock (NASDAQ: IMMX) stock price, news, charts, stock research, profile.
You can purchase shares of Immix Biopharma (NASDAQ:IMMX) through any online brokerage.
Other companies in Immix Biopharma’s space includes: Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), OncoCyte (NASDAQ:OCX), Gain Therapeutics (NASDAQ:GANX) and Intensity Therapeutics (NASDAQ:INTS).
Immix Biopharma has a consensus price target of $10.50.
The stock price for Immix Biopharma (NASDAQ: IMMX) is $1.65 last updated November 13, 2024 at 9:26 AM EST.
There are no upcoming dividends for Immix Biopharma.
Immix Biopharma’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Immix Biopharma.
Immix Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.